Alexis McGill Johnson Is Making Her Mark on Planned Parenthood

United States News News

Alexis McGill Johnson Is Making Her Mark on Planned Parenthood
United States Latest News,United States Headlines
  • 📰 ELLE Magazine (US)
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 51%

“My job is to think about how I can use Planned Parenthood’s power and influence differently,” PPact president and CEO alexismcgill says. “How do I create a framework that is going to be expansive and inclusive?'

McGill Johnson emerged from the wings in the midst of the chaos as a steady and trusted presence after a decade as a board member, including two years as chair. “When Planned Parenthood had their trouble, I was really relieved when Alexis took over,” says Senate Majority Leader Chuck Schumer. So much so that he asked her to stick around. “When she was acting president, I called her and I said, ‘We both love this organization. You’re needed to stay.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

ELLE Magazine (US) /  🏆 472. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

CDC, FDA investigating possible J&J vaccine link to rare neurological disorderCDC, FDA investigating possible J&J vaccine link to rare neurological disorderFederal health officials are looking into 'around 100 preliminary reports' of a rare but potentially serious neurological problem in people who have received J&J's Covid vaccine; more than 12.8 million J&J doses that have been administered in the U.S.
Read more »

Johnson & Johnson vaccine may pose small risk of rare neurological reaction, CDC saysJohnson & Johnson vaccine may pose small risk of rare neurological reaction, CDC saysThe CDC says it has received reports of 100 people who'd gotten the shot developing Guillain-Barré syndrome, a rare immune system disorder.
Read more »

Johnson & Johnson in discussion with FDA regarding COVID-19 vaccine side effectsJohnson & Johnson in discussion with FDA regarding COVID-19 vaccine side effectsJohnson & Johnson (JNJ.N) said on Monday it was in discussions with the U.S. Food and Drug Administration about rare cases of a neurological disorder, Guillain-Barré syndrome, that have been reported following vaccination with the Janssen COVID-19 vaccine.
Read more »

FDA adds warning to J&J vaccine for possible link to rare neurological disorderFDA adds warning to J&J vaccine for possible link to rare neurological disorderUPDATE: FDA adds warning label to the Johnson & Johnson Covid-19 vaccine following reports of 100 cases of Guillain-Barré syndrome in vaccine recipients.
Read more »



Render Time: 2025-02-27 08:03:25